Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Helmstädter

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Angewandte Chemie (International Ed. in English)|June 24, 2021
Beam Search for Automated Design and Scoring of Novel ROR Ligands with Machine Intelligence*Michael Moret, Moritz Helmstädter, Francesca Grisoni, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceMoritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
International Journal of Molecular Sciences|September 9, 2022
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor AgonistsMoritz Helmstädter, Simone Schierle, Laura Isigkeit, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.
Journal of Medicinal Chemistry|June 24, 2021
Second-Generation Dual FXR/sEH Modulators with Optimized PharmacokineticsMoritz Helmstädter, Astrid Kaiser, Steffen Brunst, et al.
Chemmedchem|April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H ModulatorsSimone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Communications Chemistry|January 27, 2023
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in micePascal Heitel, Giuseppe Faudone, Moritz Helmstädter, et al.
Chemmedchem|November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from ZafirlukastSimone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Bioorganic & Medicinal Chemistry|September 25, 2019
Structure optimization of a new class of PPARγ antagonistsVictor Hernandez-Olmos, Tilo Knape, Jan Heering, et al.
Bioorganic Chemistry|September 5, 2021
Biological evaluation and synthesis of calcitroic acidOlivia B Yu, Daniel A Webb, Elliot S Di Milo, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Angewandte Chemie (International Ed. in English)|June 24, 2021
Beam Search for Automated Design and Scoring of Novel ROR Ligands with Machine Intelligence*Michael Moret, Moritz Helmstädter, Francesca Grisoni, et al.
ACS Pharmacology & Translational Science|April 16, 2021
Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceMoritz Helmstädter, Jurema Schmidt, Astrid Kaiser, et al.
International Journal of Molecular Sciences|September 9, 2022
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor AgonistsMoritz Helmstädter, Simone Schierle, Laura Isigkeit, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
A New FXR Ligand Chemotype with Agonist/Antagonist SwitchMoritz Helmstädter, Jan Vietor, Jana Sommer, et al.
Journal of Medicinal Chemistry|June 24, 2021
Second-Generation Dual FXR/sEH Modulators with Optimized PharmacokineticsMoritz Helmstädter, Astrid Kaiser, Steffen Brunst, et al.
Chemmedchem|April 15, 2021
Development and in vitro Profiling of Dual FXR/LTA4H ModulatorsSimone Schierle, Steffen Brunst, Moritz Helmstädter, et al.
Communications Chemistry|January 27, 2023
A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in micePascal Heitel, Giuseppe Faudone, Moritz Helmstädter, et al.
Chemmedchem|November 1, 2019
Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from ZafirlukastSimone Schierle, Moritz Helmstädter, Jurema Schmidt, et al.
Bioorganic & Medicinal Chemistry|September 25, 2019
Structure optimization of a new class of PPARγ antagonistsVictor Hernandez-Olmos, Tilo Knape, Jan Heering, et al.
Bioorganic Chemistry|September 5, 2021
Biological evaluation and synthesis of calcitroic acidOlivia B Yu, Daniel A Webb, Elliot S Di Milo, et al.
Pageof 2